Selank Supplier

Direct Answer: Choosing a Qualified Selank Supplier

PX1 Research is a leading USA-based Selank supplier providing analytical-grade lyophilized peptide (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) strictly for laboratory research. Each lot undergoes independent mass spectrometry and reverse-phase high-performance liquid chromatography to guarantee purity exceeding 98%. Sourced from GMP-compliant manufacturing facilities and validated by ISO 17025 accredited laboratories, PX1 Research provides fully traceable, endotoxin-tested neuropeptides for institutional and academic research.

When evaluating a potential supplier for research compounds, principal investigators and laboratory procurement officers must prioritize verified identity, quantifiable purity, low endotoxin thresholds, and reliable domestic fulfillment. Substandard peptides containing truncated sequences, residual solvents, or heavy metal contamination can introduce significant confounding variables into preclinical models, invalidating experimental data.

Molecular Profile and Synthesis of Research-Grade Selank

Selank is a synthetic heptapeptide derived from the naturally occurring human immunomodulatory tetrapeptide Tuftsin (Thr-Lys-Pro-Arg). By appending a Pro-Gly-Pro tripeptide sequence to the C-terminus of Tuftsin, chemists stabilized the molecule against rapid enzymatic degradation by plasma carboxypeptidases and endopeptidases. The resulting primary sequence—Thr-Lys-Pro-Arg-Pro-Gly-Pro—exhibits enhanced metabolic stability in biological matrices compared to its parent peptide.

In chemical synthesis, research-grade Selank peptide is typically produced via solid-phase peptide synthesis (SPPS) using Fmoc/tBu protection strategies. Following assembly on a resin matrix, the crude peptide is cleaved, deprotected, and subjected to preparative reverse-phase high-performance liquid chromatography (RP-HPLC) to isolate the target sequence. The final product is converted to a stable salt form (typically acetate) and lyophilized to yield a fluffy, white powder suitable for reconstituting into experimental assays.

Researchers analyzing the physical properties of Selank note a molecular weight of approximately 751.9 g/mol. To verify that the peptide delivered matches these theoretical parameters, reliable suppliers must provide lot-specific Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) spectrum analyses alongside purity chromatograms.

Preclinical Mechanisms Investigated in Neurobiology Research

Preclinical literature demonstrates that Selank interacts with central nervous system pathways through several distinct biochemical mechanisms. In vitro and rodent models suggest that Selank modulates the GABAergic neurotransmitter system. Unlike conventional benzodiazepines, in vitro binding assays indicate that Selank does not bind directly to the benzodiazepine site on GABA-A receptors; rather, it appears to exert an allosteric modulatory effect, altering receptor affinity for endogenous gamma-aminobutyric acid.

Additionally, preclinical studies suggest that Selank influences the expression of neurotrophic factors. Transcriptomic evaluations in murine hippocampal tissue revealed that administration of Selank leads to rapid up-regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA expression. This neurotrophic modulation is a primary focus for investigators studying synaptic plasticity, neuronal survival, and memory consolidation in animal models.

Another documented mechanism involves the inhibition of enzymes responsible for the degradation of endogenous opioid peptides. In vitro biochemical assays show that Selank competitively inhibits enkephalin-degrading enzymes, such as neutral endopeptidase (neprilysin) and aminopeptidase N. By prolonging the half-life of endogenous leu-enkephalin and met-enkephalin in biological fluids, Selank provides a unique target for investigating endogenous analgesic and stress-response pathways. To explore broader neurochemical mechanisms, consult our preclinical peptide research library.

Essential Quality Control Criteria for Laboratory Procurement

Procuring research compounds requires a stringent vetting protocol. When selecting a research peptide supplier, analytical documentation must be scrutinized beyond simple claims of purity. Researchers should require full-spectrum documentation for every batch.

First, Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms must show a distinct single peak corresponding to the intact heptapeptide, with integrated peak areas confirming a purity of at least 98.0%. Impurities—represented by minor secondary peaks—should be identified and quantified, ensuring that deletion sequences (such as hexapeptides or pentapeptides missing proline or arginine residues) are minimized.

Second, Mass Spectrometry (MS) must report a observed mass-to-charge ratio (m/z) that aligns precisely with the calculated monoisotopic or average molecular mass of Selank ([M+H]+ ~ 752.9 Da). This step confirms chemical identity, distinguishing the target molecule from isomerized or incorrectly synthesized analogs.

Third, Endotoxin quantification via the Limulus Amebocyte Lysate (LAL) assay is critical, particularly for cell culture experiments or in vivo animal studies. Bacterial endotoxins (lipopolysaccharides) induce severe inflammatory responses in biological systems, which can completely mask or distort the biological activity of the compound under study. Quality suppliers enforce strict endotoxin limits, typically keeping levels below 0.01 EU/μg of peptide.

Finally, control over residual Trifluoroacetic Acid (TFA) is paramount. SPPS utilizes TFA during cleavage, and high residual TFA levels can exert cytotoxic effects on cell cultures or alter local pH in sensitive biochemical assays. Top-tier suppliers perform salt-exchange steps during processing to substitute TFA with acetate counterions where appropriate.

Comparative Analysis: Selank and Related Research Compounds

In neurobiological research, Selank is frequently evaluated alongside other regulatory and immunomodulatory peptides. Understanding the distinct structural and mechanistic differences between these compounds is vital when designing comparative studies or selecting control groups.

For instance, Semax is another synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10) with an added C-terminal Pro-Gly-Pro sequence. While both peptides share the stabilizing Pro-Gly-Pro motif, Semax primary sequence (Met-Glu-His-Phe-Pro-Gly-Pro) targets melanocortin receptors and cholinergic pathways, whereas Selank primarily influences GABAergic and enkephalinergic systems. Researchers investigating modified analogs often compare standard Selank with N-Acetyl Selank Amidate, a structural derivative featuring N-terminal acetylation and C-terminal amidation designed to further resist enzymatic cleavage in tissue homogenates. Furthermore, foundational studies frequently reference parent molecules like Tuftsin derivatives to establish baseline immunomodulatory activity. Review our full peptides for research catalog for comprehensive compound profiles.

Laboratory Handling, Reconstitution, and Storage Protocols

To preserve the structural integrity of synthetic peptides, proper handling and storage protocols must be implemented immediately upon receipt. Lyophilized Selank is delivered as a stable, desiccated powder. Upon arrival, un-reconstituted vials should be stored in a freezer at -20°C (or -80°C for long-term storage) to prevent hydrolytic degradation or oxidation.

When preparing the compound for in vitro or analytical testing, vials should be allowed to equilibrate to room temperature inside a desiccator before opening. This minimizes the condensation of atmospheric moisture onto the lyophilized cake, which can accelerate peptide degradation.

Reconstitution should be performed using sterile, laboratory-grade solvents appropriate for the downstream application. For most biological assays, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) is utilized. The solvent should be gently running down the inner side wall of the glass vial rather than sprayed directly onto the peptide cake. Gentle swirl mixing is recommended; rigorous vortexing or high-shear agitation should be avoided, as it can induce peptide aggregation or denaturation.

Once reconstituted into solution, peptide aliquots should be divided into single-use volumes to prevent repeated freeze-thaw cycles. Liquid solutions stored at 4°C are generally stable for short-term experimental windows (typically up to 7–14 days), whereas frozen aliquots stored at -20°C maintain stability over extended periods depending on solution concentration and buffer composition.

PX1 Research Quality Assurance and Supply Chain Standards

PX1 Research maintains rigorous quality assurance protocols to ensure that every vial of Selank delivered to laboratory customers meets exact research specifications. All manufacturing operations adhere to current Good Manufacturing Practice (cGMP) guidelines, ensuring stringent control over synthesis, purification, and sterile lyophilization environments.

Every production lot undergoes independent testing by an ISO 17025 accredited analytical laboratory located in the United States. Certificates of Analysis (COAs) generated for each batch include complete HPLC chromatograms, mass spectra, purity determinations, moisture content analyses, and quantitative endotoxin testing. This transparent verification process ensures that researchers receive reproducible reagents for critical experimental protocols.

To ensure rapid and reliable domestic delivery, PX1 Research operates dual dispatch centers located in California and Arizona. Orders placed Monday through Friday prior to cutoff times are fulfilled same-day, mitigating supply chain delays and preserving temperature stability during transit. Institutions requiring validated third-party analytical reports can access documentation directly through our laboratory portal.

Procurement Workflows for Academic and Institutional Research

Streamlining peptide procurement is critical for maintaining project timelines in active laboratories. PX1 Research offers flexible purchasing pathways tailored to academic institutions, biotechnology enterprises, and contract research organizations (CROs).

Whether acquiring individual reference standards or establishing bulk inventory for high-throughput screening, laboratories can establish a dedicated wholesale lab account. Custom manufacturing options, specific salt conversions, and specialized packaging configurations are available to support unique experimental designs.

By maintaining robust inventory levels within USA facilities, PX1 Research eliminates the customs delays, import tariffs, and temperature excursion risks associated with overseas sourcing. Researchers can confidently integrate our high-purity Selank into ongoing experimental workflows knowing that supply continuity is assured.